bronchospasm

Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.

bron·cho·spasm

(brŏng′kō-spăz′əm)

A contraction of smooth muscle in the walls of the bronchi and bronchioles, causing them to constrict.

American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

bronchospasm

(ˈbrɒŋkəʊˌspæzəm)

an abnormal contraction of the bronchi resulting in restriction of the airway

Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014

bron•cho•spasm

(ˈbrɒŋ kəˌspæz əm)

n.

spasmodic contraction of the muscular lining of the bronchi, as in asthma, causing difficulty in breathing.

[1900–05]

bron`cho•spas′tic (-ˈspæs tɪk) adj.

ThesaurusAntonymsRelated WordsSynonymsLegend:

Switch to new thesaurus

Noun

bronchospasm - a spasm of the bronchi that makes exhalation difficult and noisy; associated with asthma and bronchitis

spasm - (pathology) sudden constriction of a hollow organ (as a blood vessel)

asthma, asthma attack, bronchial asthma - respiratory disorder characterized by wheezing; usually of allergic origin

bronchitis - inflammation of the membranes lining the bronchial tubes

Translations

bron·cho·spasm

n. broncoespasmo, contracción espasmódica de los bronquios y los bronquiolos.

English-Spanish Medical Dictionary © Farlex 2012

bronchospasm

n broncoespasmo

Mentioned in ?

References in periodicals archive ?

INTRODUCTION: We as Anaesthesiologists are always worried about the occurrence of recurrent Ischemic attacks and irreversible Bronchospasm during General Anaesthesia which can lead to high mortality rates.

Anaesthestic management of elderly patient with coronary heart disease and COPD posted for shoulder disarticulation suffering from metastatic squamous cell carcinoma in upper 1/3 of humerus under combined cervical and interscalene block

The Spiriva HandiHaler (Boehringer Ingelheim/Pfizer) was approved in 2004 for the long-term maintenance treatment of bronchospasm associated with COPD, including chronic bronchitis and emphysema.

COPD inhaler deemed safe

The Spiriva HandiHaler, marketed by Boehringer Ingelheim and Pfizer, was approved in 2004 for the long-term maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.

FDA clears Spiriva inhaler of concerns about stroke, MI

The Food and Drug Administration has issued a public health advisory emphasizing the potentially lethal risk of bronchospasm in children using any of three brands of bronchodilators, as noted in two of the drugs' new medication guides and in warnings added in March to those drugs' labels.

FDA advisory issued for three bronchodilators

For that reason, we recommend routine pulse oximetry at baseline and during and after the use of restraints in case of postrestraint bronchospasm or arrhythmia.

Calming the acutely agitated

Manufactured by Novartis Pharmaceuticals Corp., Brethine is marketed for the prevention and reversal of bronchospasm. The product had sales of approximately $15 million in the U.S.

Strong Base In Technology Drives Global

In addition to bronchospasm and increased mucous production, there is a battle raging in the lung.

Asthma Revisited

Bronchospasm as a consequence of PPDA is usually seen in hairdressers, who are constantly exposed to PPDA.

Watch Out for Hair Dye

Isoproterenol Hydrochloride Injection USP is indicated for mild or transient episodes of heart block, for serious episodes of heart block and Adams-Stokes attacks, use in cardiac arrest until electric shock or pacemaker therapy, bronchospasm occurring during anesthesia, as an adjunct to fluid and electrolyte replacement therapy as well as in the treatment of hypovolemic and septic shock, low cardiac output (hypoperfusion) states, congestive heart failure and cardiogenic shock, concluded the company.

Nexus awarded US FDA for Isoproterenol Hydrochloride Injection ANDA for heart block

The dry-powder formulation of tiotropium, marketed as the Spiriva Handi-Haler by Boehringer Ingelheim and Pfizer, was approved in the United States in 2004 for long-term maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disorder, including chronic bronchitis and emphysema.

Panel backs new tiotropium claim

The FDA approved Spiriva in 2004 for the long-term treatment of bronchospasm associated with COPD.